Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 or COVID-19 disease) was declared a pandemic on 11th March 2020 by the World Health Organization. This unprecedented circumstance has challenged hospitals' response capacity, requiring significant structural and organizational changes...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in pharmacology Vol. 11; p. 572168
Main Authors Lo Bianco, Giuliano, Di Pietro, Santi, Mazzuca, Emilia, Imburgia, Aurelio, Tarantino, Luca, Accurso, Giuseppe, Benenati, Vincenzo, Vernuccio, Federica, Bucolo, Claudio, Salomone, Salvatore, Riolo, Marianna
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 09.12.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 or COVID-19 disease) was declared a pandemic on 11th March 2020 by the World Health Organization. This unprecedented circumstance has challenged hospitals' response capacity, requiring significant structural and organizational changes to cope with the surge in healthcare demand and to minimize in-hospital risk of transmission. As our knowledge advances, we now understand that COVID-19 is a multi-systemic disease rather than a mere respiratory tract infection, therefore requiring holistic care and expertise from various medical specialties. In fact, the clinical spectrum of presentation ranges from respiratory complaints to gastrointestinal, cardiac or neurological symptoms. In addition, COVID-19 pandemic has created a global burden of mental illness that affects the general population as well as healthcare practitioners. The aim of this manuscript is to provide a comprehensive and multidisciplinary insight into the complexity of this disease, reviewing current scientific evidence on COVID-19 management and treatment across several medical specialties involved in the in-hospital care of these patients.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Edited by: Brian Godman, University of Strathclyde, United Kingdom
This article was submitted to Pharmaceutical Medicine and Outcomes Research, a section of the journal Frontiers in Pharmacology
Godfrey Mutashambara Rwegerera, University of Botswana, Botswana
Reviewed by: Luis Laranjeira, Eli Lilly, Portugal
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2020.572168